A number of anti-androgens, which directly bind to the ligand-binding domain of AR and prevent its activation by ligand [93], are used to treat prostate cancer as well as other diseases such as polycystic ovarian syndrome, alopecia and are being trialled for breast cancer [94]. Here, AR is linked to prostate carcinoma.